Objectives: Daylight-PDT (DL-PDT) is a soft and progressive, painless, mode of PpIX activation as it is produced (30 min of incubation of topical ALA or MAL, 2h continuous exposure). The clinical adventure of DL use for PDT began in the early 20th century but this technique was forgotten until Pr Wulf et al revived it. The first proof of concept study on the efficacy to treat actinic keratoses of the face and scalp was published in 2008. Its non-inferiority has now been proven in numerous multicenter randomized clinical trials. Photorejuvenation (PR) and acne are possible off-label cosmetic uses of PDT
Introduction: PR-PDT ( based on clinical, histological and, with immunohistochemical markers assessment, studies) can both normalize UV-induced atypical keratinocytes and markers (decrease of baseline epidermal p53 level ...) and induce a dermal reshaping by direct effect on dermal FB (ERK signaling pathway ) and indirect epithelial- mesenchymal interactions (IL, TNF, MMPs, ARNm coll…) even for low-level PDT (6J/cm²). Clinical results, even with daylight use, show that tone, lentigos, skin roughness, texture and fine wrinkles can be improved.
Materials / method: Protocols of prior microporation -microneedling, sandpaper abrasion or fractional laser) of the treated skin before ALA or MAL application (assisted delivery – ‘’intensified’’ PDT) are used to enhance PpIX formation and efficiency of PDT sessions but with severe pain rated from 6 to 8 on 10 visual analogic scales. These scores are not acceptable for rejuvenation techniques. The combination of ALA or MAL-assisted delivery and daylight exposure offers a dual benefit: increased efficiency and very low pain scores (0-1 on VAS). It can also be used on extrafacial areas such as the decolletage.
Results: For acne, PDT is always a 2nd or 3rd line of treatment. In the last Cochrane review, among all light therapies, only red-LED MAL-PDT has demonstrated a low-to moderate evidence of efficacy. Applied this way it can be efficient on inflammatory and non inflammatory lesions but adverse effects range from severe to unbearable (intense pain during illumination, volcanic eruption and social eviction of up to 8-10 days, prolonged risks of erythema or post-inflammatory hyperpigmentation…). Daylight use could be an alternative but there is no reference in the literature except for 1 recent Korean study
Conclusion: reporting the absence of significant effect in non inflammatory lesions (Tae In Kim et al., 2017). In the future it could interesting to use creams containing photosensitizers at low dosage and daily...daylight use ! (as it has been published by Kwon et al in 2016 J dermatol.)
利益冲突声明
您有否接受任何资金来支持研究这个主题?
否
您是否接受过关于这项研究的任何酬金或其他报酬?
否
你是否和任何与您的研究所涉及的药物,材料或工具有密切联系的实体存在财务关系?
否
你是否拥有或者您已经为您此研究中的工具,药物或材料申请任何专利?
否
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。